title: Hepatocellular injuries observed in patients with an eating disorder prior to nutritional treatment.
abstract: OBJECTIVE
  Although hepatocellular injuries are occasionally observed in patients with an eating disorder, such as anorexia nervosa (AN), it remains unclear how malnutrition in patients with AN causes hepatocellular damage. In this retrospective study, we aimed to reveal the characteristics of hepatocellular injuries in patients with an eating disorder without any nutritional treatment, to eliminate the possible hepatotoxic effects of nutritional support.
  
  
  METHODS
  Twenty-five patients with an eating disorder who visited St. Luke's International Hospital were enrolled. No nutritional treatment had been performed for these patients. The diagnosis of eating disorder as well as typing (anorexia nervosa or bulimia nervosa) was made according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-4). We reviewed the charts of these patients and examined the clinical parameters.
  
  
  RESULTS
  Elevation of serum alanine aminotransferase (ALT) was found in 13 out of 25 (52%), all of whom were categorized as AN. In 13 AN patients with elevated ALT, the median of serum ALT values was 92 [39-438] IU/L. The body mass index (BMI) was significantly lower (13.5 vs. 17.3, p=0.011), and the duration since the onset of AN was shorter (4.2 years vs. 8.9 years, p=0.037) in patients with elevated ALT. The age was younger in patients with elevated ALT, even though not significant (24.5 vs. 29.8, p=0.139). Logistic regression analysis revealed that only BMI was a significant determinant for the development of hepatocellular injuries (OR=3.46; 95% CI 1.06-11.34, p=0.041). Imaging studies failed to demonstrate any abnormalities, including fatty liver.
  
  
  CONCLUSIONS
  The current study indicated that lower BMI might significantly contribute to the development of hepatocellular injuries in AN patients prior to any nutritional treatments.
authors.affiliation: Department of Internal Medicine, St. Luke's International Hospital, Tokyo. tukamsa@luke.or.jp
authors.forename: Masayo
authors.initials: M
authors.lastname: Tsukamoto
authors.forename: Atsushi
authors.initials: A
authors.lastname: Tanaka
authors.forename: Motoe
authors.initials: M
authors.lastname: Arai
authors.forename: Naoki
authors.initials: N
authors.lastname: Ishii
authors.forename: Daisuke
authors.initials: D
authors.lastname: Ohta
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Horiki
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Fujita
mesh_terms: D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D000856:Anorexia Nervosa / Q000150:complications* / Q000178:diet therapy / Q000503:physiopathology*; D015992:Body Mass Index; D005234:Fatty Liver / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology*; D001068:Feeding and Eating Disorders / Q000150:complications* / Q000178:diet therapy / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging / Q000378:metabolism; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
chemical_list: D000410:Alanine Transaminase